Skip to main content

Table 4 Characteristics of seven statistically significant age-treatment interactions reported by authors

From: Age-treatment subgroup analyses in Cochrane intervention reviews: a meta-epidemiological study

Comparison

Population characteristics

Outcome

Primary outcome*

Specified in methods?†

Reported age subgroup levels

Effect size [95% CI]‡

RCTs per subgroup level

RCTs across all levels§

P value

Biological/clinical rationale¶

Botulinum toxin vs surgery (2017)

Children and adults with strabismus suitable for treatment with botulinum toxin to align the angle of deviation

Improved ocular alignment ≤ 10 prism dioptres

Yes

No

Children

RR 0.91 [0.71, 1.16]

2

0

0.04

No

Adults

RR 0.38 [0.17, 0.85]

1

Digital intervention vs no/minimal intervention (2017)

Individuals in the community with hazardous or harmful alcohol consumptions directed toward any digital intervention

Quantity of drinking (grams/week), based on the longest follow-up

Yes

Yes

Adolescents/young adults

MD − 13.44 [− 19.27, − 7.61]

28

0

0.002

No

Adults

MD − 56.05 [− 82.08, − 30.02]

14

Supplementary feeding vs comparator by age of children (2012)

Children from low- and middle-income countries born at term, from birth to 5 years old

Weight gain (kg) during the intervention

Yes

Yes

Children younger than 24 months

MD − 0.01 [− 0.09, 0.07]

4

0

0.008

No

Children older than 24 months

MD 0.22 [0.07, 0.37]

1

Diet plus physical activity vs comparator (2017)

Individuals diagnosed with intermediate hyperglycemia or prediabetes at increased risk of developing type II diabetes mellitus

Incidence of type 2 diabetes

Yes

Yes

Ages < 50 years

RR 0.70 [0.57, 0.85]

2

0

0.009

No

Ages ≥ 50 years

RR 0.50 [0.44, 0.58]

9

2-h plasma glucose

No

Yes

Ages < 50 years

MD − 1.62 [− 2.49, − 0.76]

2

0

0.003

No

Ages ≥ 50 years

MD − 0.27 [− 0.49, − 0.05]

7

Colony-stimulating factor plus antibiotics vs antibiotics alone (2014)

Individuals undergoing chemotherapy for cancer who experienced neutropenia and fever

Time to neutrophil recovery

No

Yes

Children

RR 0.80 [0.66, 0.97]

1

0

0.02

No

Adults

RR 0.45 [0.29, 0.70]

5

Fluticasone propionate vs beclomethasone dipropionate or budesonide, parallel-group studies: dose ratio 1:2 subgroup by age (2007)

Children (> 2 years) and adults with a clinical diagnosis of asthma

Change in Forced Expiratory Volume 1 compared to baseline

Unclear

Yes

Children

MD − 0.04 [− 0.10, 0.02]

2

0

0.02

No

Adults

MD 0.04 [0.00 0.08]

10

  1. MD mean difference, RCT randomized controlled trial, RR risk ratio
  2. *Is the outcome for this analysis specified as the primary outcome in the text of the review?
  3. †Is the age-treatment subgroup analysis outlined in the Methods section of the review?
  4. ‡Effect sizes are reported using the statistical methods specified in the forest plot
  5. §Subgroups with RCTs that include data for all subgroup levels of the analysis
  6. ¶Did the reviews discuss the subgroup analyses and provided clinical or biological rationale?